MR编号 | FR/V/0352/001 |
---|
药品名称 | Hipragumboro GM97 |
---|
活性成分 | - Infectious Bursal Disease (Gumboro) Virus 10.0 EID50/dose
|
---|
剂型 | Oral suspension |
---|
上市许可持有人 | Laboratorios Hipra, S.A
Avda. La Selva, 135 E-17170 Amer (Girona)
Spain |
---|
参考成员国 - 产品名称 | France (FR) HIPRAGUMBORO-G97 |
---|
互认成员国 - 产品名称 | - Ireland (IE)
- Bulgaria (BG)
- United Kingdom (Northern Ireland) (XI)
Hipragumboro G97 - Germany (DE)
Hipragumboro G97 - Belgium (BE)
Hipragumboro-GM97 - Netherlands (NL)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Poland (PL)
- Hungary (HU)
- Czechia (CZ)
- Slovakia (SK)
- Estonia (EE)
- Austria (AT)
- Spain (ES)
- Latvia (LV)
- Lithuania (LT)
|
---|
许可日期 | 2008/04/05 |
---|
最近更新日期 | 2024/11/18 |
---|
药物ATC编码 | - QI01AD09 avian infectious bursal disease virus (gumboro disease)
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|